Definium Therapeutics, Inc. (MNMD)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch MNMD
Latest sale
$397k
Sep 25 · Routine
Form 4 sales
72
On record
Form 144 notices
48
Proposed sales
Sold, last 30 days
None
No Form 4 sale
Sold, last 90 days
$3M
6 sales by 5 insiders
0.06% of shares outstanding
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

40
Routine
22
Plan not stated
10
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. Sep 25, 2026Routine

    Daniel Karlin, Chief Medical Officer, sold 1.4% of their holdings

    $397k10,853 shares at $36.57

    Filed Sep 29, 2026Form 4

  2. Sep 25, 2026Routine

    Robert Barrow, Chief Executive Officer, sold 1.4% of their holdings

    $1.2M31,550 shares at $36.57

    Filed Sep 29, 2026Form 4

  3. Sep 25, 2026Routine

    Matthew T. Wiley, Chief Commercial Officer, sold 0.9% of their holdings

    $113k3,097 shares at $36.57

    Filed Sep 29, 2026Form 4

  4. Sep 25, 2026Routine

    Mark Sullivan, Chief Legal Officer, sold 2.8% of their holdings

    $514k14,051 shares at $36.57

    Filed Sep 29, 2026Form 4

  5. Sep 25, 2026Routine

    Brandi Roberts, Chief Financial Officer, sold 0.8% of their holdings

    $123k3,377 shares at $36.57

    Filed Sep 29, 2026Form 4

  6. Sep 25, 2026Notice

    Mark Sullivan, Chief Legal Officer, filed a notice to sell 14,051 shares

    $516k14,051 shares

    Filed Sep 25, 2026Form 144

  7. Sep 25, 2026Notice

    Brandi Roberts, Chief Financial Officer, filed a notice to sell 3,377 shares

    $124k3,377 shares

    Filed Sep 25, 2026Form 144

  8. Sep 25, 2026Notice

    Matthew T. Wiley, Chief Commercial Officer, filed a notice to sell 3,097 shares

    $114k3,097 shares

    Filed Sep 25, 2026Form 144

  9. Sep 25, 2026Notice

    Daniel Karlin, Chief Medical Officer, filed a notice to sell 10,853 shares

    $399k10,853 shares

    Filed Sep 25, 2026Form 144

  10. Sep 25, 2026Notice

    Robert Barrow, Chief Executive Officer, filed a notice to sell 31,550 shares

    $1.2M31,550 shares

    Filed Sep 25, 2026Form 144

10 of 120

Every transaction

Every transaction on a Form 4 or Form 5 for MNMD
TradedFiledStockNameRoleWhatAmountPriceValueHeld afterSource
Sep 25, 2026Sep 29, 2026MNMDDaniel KarlinChief Medical OfficerSold10,853$36.57$397k792,846SEC
Sep 25, 2026Sep 29, 2026MNMDRobert BarrowChief Executive OfficerSold31,550$36.57$1.2M2.2MSEC
Sep 25, 2026Sep 29, 2026MNMDMatthew T. WileyChief Commercial OfficerSold3,097$36.57$113k359,036SEC
Sep 25, 2026Sep 29, 2026MNMDMark SullivanChief Legal OfficerSold14,051$36.57$514k494,228SEC
Sep 25, 2026Sep 29, 2026MNMDBrandi RobertsChief Financial OfficerSold3,377$36.57$123k394,528SEC
Sep 18, 2026Sep 18, 2026MNMDAndreas KrebsDirectorExercised or settledStock Option (Right to Buy)1,6290SEC
Sep 18, 2026Sep 18, 2026MNMDAndreas KrebsDirectorExercised options1,629$35.52$58k21,402SEC
Sep 18, 2026Sep 18, 2026MNMDCarol A ValloneDirectorExercised or settledStock Option (Right to Buy)1,0860SEC
Sep 18, 2026Sep 18, 2026MNMDCarol A ValloneDirectorExercised options1,086$35.52$39k22,296SEC
Sep 14, 2026Sep 14, 2026MNMDDaniel KarlinChief Medical OfficerAwarded200,000803,699SEC
Sep 14, 2026Sep 14, 2026MNMDMatthew T. WileyChief Commercial OfficerAwarded125,000362,133SEC
Sep 14, 2026Sep 14, 2026MNMDMark SullivanChief Legal OfficerAwarded125,000508,279SEC
Sep 14, 2026Sep 14, 2026MNMDBrandi RobertsChief Financial OfficerAwarded125,000397,905SEC
Sep 14, 2026Sep 14, 2026MNMDRobert BarrowChief Executive OfficerAwarded750,0002.2MSEC
Sep 3, 2026Sep 4, 2026MNMDRobert BarrowChief Executive OfficerSold19,023$37.94$722k1.5MSEC
Sep 2, 2026Sep 4, 2026MNMDRobert BarrowChief Executive OfficerAwarded40,0001.5MSEC
Aug 12, 2026Aug 12, 2026MNMDRobert BarrowChief Executive OfficerAwarded375,0001.5MSEC
Aug 12, 2026Aug 12, 2026MNMDDaniel KarlinChief Medical OfficerAwarded100,000603,282SEC
Aug 12, 2026Aug 12, 2026MNMDMark SullivanChief Legal OfficerAwarded62,500383,071SEC
Aug 12, 2026Aug 12, 2026MNMDMatthew T. WileyChief Commercial OfficerAwarded62,500237,133SEC
Aug 12, 2026Aug 12, 2026MNMDBrandi RobertsChief Financial OfficerAwarded62,500271,987SEC
Jun 25, 2026Jun 26, 2026MNMDMark SullivanChief Legal OfficerSold13,008$45.03$586k320,571SEC
Jun 25, 2026Jun 26, 2026MNMDDaniel KarlinChief Medical OfficerSold10,035$45.03$452k503,282SEC
Jun 25, 2026Jun 26, 2026MNMDBrandi RobertsChief Financial OfficerSold3,013$45.03$136k209,487SEC
Jun 25, 2026Jun 26, 2026MNMDRobert BarrowChief Executive OfficerSold29,208$45.03$1.3M1.1MSEC
Jun 25, 2026Jun 26, 2026MNMDMatthew T. WileyChief Commercial OfficerSold2,867$45.03$129k174,633SEC
Jun 22, 2026Jun 22, 2026MNMDRobert BarrowChief Executive OfficerAwarded375,0001.1MSEC
Jun 22, 2026Jun 22, 2026MNMDMatthew T. WileyChief Commercial OfficerAwarded62,500177,500SEC
Jun 22, 2026Jun 22, 2026MNMDBrandi RobertsChief Financial OfficerAwarded62,500212,500SEC
Jun 22, 2026Jun 22, 2026MNMDMark SullivanChief Legal OfficerAwarded62,500333,579SEC
Jun 22, 2026Jun 22, 2026MNMDDaniel KarlinChief Medical OfficerAwarded100,000513,317SEC
Jun 11, 2026Jun 15, 2026MNMDRoger CrystalDirectorAwardedStock Option (Right to Buy)19,18819,188SEC
Jun 11, 2026Jun 15, 2026MNMDRoger CrystalDirectorAwarded4,66624,289SEC
Jun 11, 2026Jun 15, 2026MNMDDavid W GryskaDirectorAwardedStock Option (Right to Buy)19,18819,188SEC
Jun 11, 2026Jun 15, 2026MNMDDavid W GryskaDirectorAwarded4,66619,900SEC
Jun 11, 2026Jun 15, 2026MNMDCarol A ValloneDirectorAwardedStock Option (Right to Buy)19,18819,188SEC
Jun 11, 2026Jun 15, 2026MNMDCarol A ValloneDirectorAwarded4,66621,210SEC
Jun 11, 2026Jun 15, 2026MNMDAndreas KrebsDirectorAwardedStock Option (Right to Buy)19,18819,188SEC
Jun 11, 2026Jun 15, 2026MNMDAndreas KrebsDirectorAwarded4,66619,773SEC
Jun 11, 2026Jun 15, 2026MNMDRoger AdsettDirectorAwardedStock Option (Right to Buy)14,62014,620SEC
Jun 11, 2026Jun 15, 2026MNMDRoger AdsettDirectorAwarded3,5553,555SEC
Jun 11, 2026Jun 15, 2026MNMDSuzanne Louise BruhnDirectorAwardedStock Option (Right to Buy)19,18819,188SEC
Jun 11, 2026Jun 15, 2026MNMDSuzanne Louise BruhnDirectorAwarded4,66624,289SEC
Mar 25, 2026Mar 26, 2026MNMDDaniel KarlinChief Medical OfficerSold8,018$18.47$148k413,317SEC
Mar 25, 2026Mar 26, 2026MNMDMark SullivanChief Legal OfficerSold10,702$18.47$198k271,079SEC
Mar 25, 2026Mar 26, 2026MNMDRobert BarrowChief Executive OfficerSold24,431$18.47$451k752,454SEC
Feb 3, 2026Feb 5, 2026MNMDMatthew T. WileyChief Commercial OfficerAwarded115,000115,000SEC
Feb 3, 2026Feb 5, 2026MNMDBrandi RobertsChief Financial OfficerAwarded150,000150,000SEC
Feb 3, 2026Feb 5, 2026MNMDMark SullivanChief Legal OfficerAwarded125,000407,576SEC
Feb 3, 2026Feb 5, 2026MNMDDaniel KarlinChief Medical OfficerAwarded150,000575,025SEC
Page 1

Sales, notices and lockups (120)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for MNMD
Source
Sep 25, 2026Sep 29, 2026Daniel KarlinMNMDChief Medical OfficerForm 4 sale10,853$397k1.4%RoutineSEC
Sep 25, 2026Sep 29, 2026Robert BarrowMNMDChief Executive OfficerForm 4 sale31,550$1.2M1.4%RoutineSEC
Sep 25, 2026Sep 29, 2026Matthew T. WileyMNMDChief Commercial OfficerForm 4 sale3,097$113k0.9%RoutineSEC
Sep 25, 2026Sep 29, 2026Mark SullivanMNMDChief Legal OfficerForm 4 sale14,051$514k2.8%RoutineSEC
Sep 25, 2026Sep 29, 2026Brandi RobertsMNMDChief Financial OfficerForm 4 sale3,377$123k0.8%RoutineSEC
Sep 25, 2026Sep 25, 2026Mark SullivanMNMDChief Legal OfficerForm 144 notice14,051$516kNoticeSEC
Sep 25, 2026Sep 25, 2026Brandi RobertsMNMDChief Financial OfficerForm 144 notice3,377$124kNoticeSEC
Sep 25, 2026Sep 25, 2026Matthew T. WileyMNMDChief Commercial OfficerForm 144 notice3,097$114kNoticeSEC
Sep 25, 2026Sep 25, 2026Daniel KarlinMNMDChief Medical OfficerForm 144 notice10,853$399kNoticeSEC
Sep 25, 2026Sep 25, 2026Robert BarrowMNMDChief Executive OfficerForm 144 notice31,550$1.2MNoticeSEC
Sep 3, 2026Sep 4, 2026Robert BarrowMNMDChief Executive OfficerForm 4 sale19,023$722k1.3%RoutineSEC
Sep 3, 2026Sep 3, 2026Robert BarrowMNMDChief Executive OfficerForm 144 notice19,023$718kNoticeSEC
Jun 25, 2026Jun 26, 2026Mark SullivanMNMDChief Legal OfficerForm 4 sale13,008$586k3.9%RoutineSEC
Jun 25, 2026Jun 26, 2026Daniel KarlinMNMDChief Medical OfficerForm 4 sale10,035$452k2.0%RoutineSEC
Jun 25, 2026Jun 26, 2026Brandi RobertsMNMDChief Financial OfficerForm 4 sale3,013$136k1.4%RoutineSEC
Jun 25, 2026Jun 26, 2026Robert BarrowMNMDChief Executive OfficerForm 4 sale29,208$1.3M2.6%RoutineSEC
Jun 25, 2026Jun 26, 2026Matthew T. WileyMNMDChief Commercial OfficerForm 4 sale2,867$129k1.6%RoutineSEC
Jun 25, 2026Jun 25, 2026Mark SullivanMNMDChief Legal OfficerForm 144 notice13,008$548kNoticeSEC
Jun 25, 2026Jun 25, 2026Matthew T. WileyMNMDChief Commercial OfficerForm 144 notice2,867$121kNoticeSEC
Jun 25, 2026Jun 25, 2026Brandi RobertsMNMDChief Financial OfficerForm 144 notice3,013$127kNoticeSEC
Jun 25, 2026Jun 25, 2026Daniel KarlinMNMDChief Medical OfficerForm 144 notice10,035$423kNoticeSEC
Jun 25, 2026Jun 25, 2026Robert BarrowMNMDChief Executive OfficerForm 144 notice29,208$1.2MNoticeSEC
Mar 25, 2026Mar 26, 2026Daniel KarlinMNMDChief Medical OfficerForm 4 sale8,018$148k1.9%RoutineSEC
Mar 25, 2026Mar 26, 2026Mark SullivanMNMDChief Legal OfficerForm 4 sale10,702$198k3.8%RoutineSEC
Mar 25, 2026Mar 26, 2026Robert BarrowMNMDChief Executive OfficerForm 4 sale24,431$451k3.1%RoutineSEC
Mar 25, 2026Mar 25, 2026Robert BarrowMNMDChief Executive OfficerForm 144 notice24,431$451kNoticeSEC
Mar 25, 2026Mar 25, 2026Daniel KarlinMNMDChief Medical OfficerForm 144 notice8,018$148kNoticeSEC
Mar 25, 2026Mar 25, 2026Mark SullivanMNMDChief Legal OfficerForm 144 notice10,702$198kNoticeSEC
Dec 29, 2025Dec 29, 2025Daniel KarlinMNMDChief Medical OfficerForm 144 notice5,600$74kNoticeSEC
Dec 29, 2025Dec 29, 2025Mark SullivanMNMDChief Legal OfficerForm 144 notice11,276$148kNoticeSEC
Dec 29, 2025Dec 29, 2025Robert BarrowMNMDChief Executive OfficerForm 144 notice25,791$339kNoticeSEC
Dec 26, 2025Dec 29, 2025Daniel KarlinMNMDChief Medical OfficerForm 4 sale5,600$74k1.3%RoutineSEC
Dec 26, 2025Dec 29, 2025Robert BarrowMNMDChief Executive OfficerForm 4 sale25,791$339k3.2%RoutineSEC
Dec 26, 2025Dec 29, 2025Mark SullivanMNMDChief Legal OfficerForm 4 sale11,276$148k3.8%RoutineSEC
Sep 25, 2025Sep 26, 2025Mark SullivanMNMDChief Legal OfficerForm 4 sale11,278$110k3.7%RoutineSEC
Sep 25, 2025Sep 26, 2025Robert BarrowMNMDChief Executive OfficerForm 4 sale25,797$252k3.1%RoutineSEC
Sep 25, 2025Sep 26, 2025Daniel KarlinMNMDChief Medical OfficerForm 4 sale7,704$75k1.8%RoutineSEC
Sep 25, 2025Sep 25, 2025Mark SullivanMNMDChief Legal OfficerForm 144 notice11,278$110kNoticeSEC
Sep 25, 2025Sep 25, 2025Daniel KarlinMNMDChief Medical OfficerForm 144 notice7,704$75kNoticeSEC
Sep 25, 2025Sep 25, 2025Robert BarrowMNMDChief Executive OfficerForm 144 notice25,797$252kNoticeSEC
Jun 25, 2025Jun 26, 2025Mark SullivanMNMDChief Legal OfficerForm 4 sale11,491$78k3.6%RoutineSEC
Jun 25, 2025Jun 26, 2025Daniel KarlinMNMDChief Medical OfficerForm 4 sale7,848$53k1.8%RoutineSEC
Jun 25, 2025Jun 26, 2025Robert BarrowMNMDChief Executive OfficerForm 4 sale26,491$180k3.1%RoutineSEC
Jun 25, 2025Jun 25, 2025Daniel KarlinMNMDChief Medical OfficerForm 144 notice7,848$53kNoticeSEC
Jun 25, 2025Jun 25, 2025Mark SullivanMNMDChief Legal OfficerForm 144 notice11,491$78kNoticeSEC
Jun 25, 2025Jun 25, 2025Robert BarrowMNMDChief Executive OfficerForm 144 notice26,491$180kNoticeSEC
Mar 25, 2025Mar 26, 2025Robert BarrowMNMDChief Executive OfficerForm 4 sale21,208$143k2.4%RoutineSEC
Mar 25, 2025Mar 26, 2025Daniel KarlinMNMDChief Medical OfficerForm 4 sale6,836$46k1.5%RoutineSEC
Mar 25, 2025Mar 26, 2025Mark SullivanMNMDChief Legal OfficerForm 4 sale6,576$44k2.0%RoutineSEC
Mar 25, 2025Mar 26, 2025Carrie LiaoMNMDChief Accounting OfficerForm 4 sale2,347$16k1.6%RoutineSEC
Showing the first 50